SARS-CoV-2 spike binding antibodies

1. Tozinameran increases SARS-CoV-2 spike binding antibodies in humans.

   “The first two vaccine doses elicited potent SARS-CoV-2 spike binding antibodies in individuals up to 80 years.”

   Human trialafter first two doses

   Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection

   NPJ vaccines·Feb 20, 2024

More on Tozinameran